31 min listen
E-Cigarettes for Harm Reduction in Tobacco Use
E-Cigarettes for Harm Reduction in Tobacco Use
ratings:
Length:
37 minutes
Released:
Sep 3, 2021
Format:
Podcast episode
Description
CHEST September 2021, Volume 160, Issue 3
Clive D. Bates, MA, MSc, Hasmeena Kathuria, MD, and Frank T. Leone, MD, MS, join CHEST Podcast Moderator, Gretchen Winter, MD, to discuss the pros and cons of utilizing e-cigarettes for harm reduction in tobacco use.
DOI: https://doi.org/10.1016/j.chest.2021.04.046
DOI: https://doi.org/10.1016/j.chest.2021.04.045
DOI: https://doi.org/10.1016/j.chest.2021.04.044
DOI: https://doi.org/10.1016/j.chest.2021.04.047
Clive D. Bates, MA, MSc, Hasmeena Kathuria, MD, and Frank T. Leone, MD, MS, join CHEST Podcast Moderator, Gretchen Winter, MD, to discuss the pros and cons of utilizing e-cigarettes for harm reduction in tobacco use.
DOI: https://doi.org/10.1016/j.chest.2021.04.046
DOI: https://doi.org/10.1016/j.chest.2021.04.045
DOI: https://doi.org/10.1016/j.chest.2021.04.044
DOI: https://doi.org/10.1016/j.chest.2021.04.047
Released:
Sep 3, 2021
Format:
Podcast episode
Titles in the series (100)
Can the Interstitial Lung Disease-GAP Model Be Used to Accurately Predict Mortality in Chronic ILD Subtypes?: Christopher J. Ryerson, MD, and editorialist Athol U. Wells, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the study by Dr. Ryerson and others extending the use of the GAP risk prediction model (which is based on gender, age, and l... by CHEST Journal Podcasts